Insiders Hepion Pharmaceuticals, Inc.

Equities

HEPA

US4268973025

Market Closed - Nasdaq Other stock markets 01:30:00 15/05/2024 am IST			5-day change	1st Jan Change
1.29 ^USD	+6.61%		-5.84%	-60.19%

22/04	Sector Update: Health Care Stocks Increase Late Afternoon	MT
22/04	Sector Update: Health Care	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hepion Pharmaceuticals, Inc. Appoints Michael Purcell to Its Board of Directors	06/03	CI
Hepion Pharmaceuticals, Inc. Announces Board Changes	21/02	CI
Hepion Pharmaceuticals, Inc. Announces Resignation of Anand Reddi from the Board of Directors	08/02	CI
Hepion Pharmaceuticals Approves Restructuring Plan to Preserve Capital, Launches Strategic Review Process	07/12	MT
Hepion Pharmaceuticals, Inc. Announces Resignation of Robert Foster as Director	07/12	CI
Hepion Pharmaceuticals, Inc. Announces CEO Changes	07/12	CI
Aurinia Pharmaceuticals Appoints Robert Foster as Part of Deal With Shareholder MKT Capital	21/23/21	MT
Hepion Pharmaceuticals, Inc. Announces Resignation of Dr. Todd Hobbs, as the Chief Medical Officer, Effective September 29, 2023	07/23/07	CI
Hepion Pharmaceuticals, Inc. Announces Board Appointments	30/23/30	CI
Hepion Pharmaceuticals, Inc. Announces Board Changes	28/22/28	CI
Hepion Pharmaceuticals Names Launa Aspeslet as Chief Operating Officer	14/22/14	MT
Hepion Pharmaceuticals, Inc. Appoints Dr. Launa J. Aspeslet as Chief Operating Officer	14/22/14	CI
Hepion Pharmaceuticals Appoints Eddie C. Cheung to Lead the Company’s Strategic Medical Affairs in Asia	15/22/15	CI
Hepion Pharmaceuticals, Inc Announces Demise of Thomas Adams, Ph.D., Member of Its Board of Directors	12/22/12	CI
Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer	10/21/10	CI
Hepion Pharmaceuticals, Inc. Announces Dr. Peter Wijngaard Has Joined Its Board of Directors	11/20/11	CI
Stephen Harrison Joins Hepion Pharmaceuticals as Consultant Medical Director	10/19/10	CI
Hepion Pharmaceuticals, Inc. Announces Executive Promotions	04/19/04	CI
Hepion Pharmaceuticals, Inc. Appoints Stephen Harrison to its Scientific Advisory Board	07/19/07	CI
ContraVir Pharmaceuticals, Inc. will Change its Name to Hepion Pharmaceuticals, Inc	23/19/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Hepion Pharmaceuticals, Inc.

Equities

HEPA

US4268973025

Insiders

Filters